Form 4: Quest Diagnostics Executive Sam Samad Reports Stock Sale to Cover Tax Obligations
SEC Form 4 Filing
Executive Vice President & CFO of Quest Diagnostics, Sam Samad, reports the sale of 656 shares of common stock to cover tax obligations arising from vesting of restricted share units.
Summary
- On February 28, 2024, Sam Samad, Executive Vice President & CFO of Quest Diagnostics, sold 656 shares of common stock.
- The sale was executed to satisfy tax obligations related to the vesting of restricted share units.
- The price per share was $126.36.
- Following the transaction, Samad directly owns 21,332 shares of Quest Diagnostics common stock.
Sentiment
Score: 5
Explanation: This is a neutral event. The sale is related to tax obligations, which is a normal part of executive compensation. It doesn't necessarily indicate a positive or negative outlook on the company.
Industry Context
Form 4 filings are routine disclosures required by the SEC when company insiders, like executives and directors, trade their company's stock. These filings provide transparency into insider transactions and can be monitored by investors for insights into management's perspective on the company's value and prospects. This transaction is related to tax obligations, which is a common reason for such sales.
Key Dates
| Date | Description |
|---|---|
| 02/28/2024 | Date of the stock sale transaction. |
| 03/01/2024 | Date of signature by Sean D. Mersten, Attorney in Fact for Sam Samad. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.